Wade Thompson

Spooked by long lists of meds? 👻 Check out CADeN’s resources to help you tackle spooky (risky) meds! Whether you’re looking to identify inappropriate meds, engage in #deprescribing conversations with patients & caregivers, or develop a safe deprescribing protocol, check out our tools to cast those spooky meds away! deprescribingnetwork.ca/useful-resourc…

We're recruiting #pharmacists and primary care providers in BC for a research study. We're developing quality indicators for community #pharmacist prescribing of minor ailments and contraception in BC. Contact Dr. Karen Dahri (Karen.Dahri@ubc.ca) to learn more.

🩺Calling all medical doctors, pharmacists, and nurses! 💊What should deprescribing recommendations look like? 👩‍⚕️Share your thoughts and help shape the future of healthcare: tinyurl.com/deprescribingr… @deprescribing @DeprescribeNet @DeprescribeUS @NDeprescribing @EDeprescribeN

@markhoro thanks!

@wadddee Great paper Wade - well done!

Sedative use in BC 2012-21: tale as old as time ↘️ BZD/Z drug use offset by ↗️low dose trazodone, quetiapine use ⚠️Traz and QTP = known harms and ??? benefit for insomnia ❓need to stop only focusing our #deprescribing efforts on BZDs and Z drugs 👉 rdcu.be/dXfAR

Nov 6 noon: #deprescribing enthusiasts, especially @pharmacists This webinar (using #tramadol example) will help empower you to do drugectomies in your #longtermcare facility, with applications for clinic + community too! #polypharmacy @bc_pharmacy @deprescribing @SeniorCareRx

🧵Safe diabetes treatment for older adults 👉🏽ti.ubc.ca/letter151 1/ Risks of harms from side effects ⚠️For diabetes meds, low blood sugar is one of the most important side effects ⚠️Sulfonylureas & insulins are the drugs most likely to cause low blood sugar #ptsafety #T2DM

🆕 TI Therapeutics Letter 151 🎺 Minimizing harms of tight glycemic control in older people with type 2 #diabetes 👉🏽ti.ubc.ca/letter151 "For most older adults (65 years or older) with type 2 diabetes who have an A1c below 7%, sulfonylureas or insulin do more harm than good"

The Organising Committee is finalising the last details of the conference! Are you ready folks? 🤩🤩🤩 Looking forward to seeing you!

🧐 𝗪𝗵𝗮𝘁 𝘀𝗵𝗼𝘂𝗹𝗱 𝗱𝗲𝗽𝗿𝗲𝘀𝗰𝗿𝗶𝗯𝗶𝗻𝗴 𝗿𝗲𝗰𝗼𝗺𝗺𝗲𝗻𝗱𝗮𝘁𝗶𝗼𝗻𝘀 𝗹𝗼𝗼𝗸 𝗹𝗶𝗸𝗲? ✅ Share your insights by taking our survey! 📢 tinyurl.com/deprescribingr… @DeprescribeNet @DeprescribeUS @NDeprescribing

Presented at #ESCardio: Among patients with a previous myocardial infarction, interruption of long-term beta-blocker therapy was not found to be noninferior to continuation with respect to adverse events at a median of 3 years. Full ABYSS trial results: nej.md/3MeRHOi

11/n Stay tuned for our statin deprescribing guideline coming soon! 😃

10/n Thank you to our stellar team for all of your hard work on this review! @ParagGoyalMD @pharmacist_lisa @LiseBjerre @ArdenBarry @DeprescribeNet

1/n Our @deprescribing team gets asked about statins A LOT We did a systematic review on statin discontinuation which came out last month in @AGSJournal Join me for few take-aways 👇 #deprescribing #CardioTwitter agsjournals.onlinelibrary.wiley.com/doi/10.1111/jg…